Tyers Asset Management LLC trimmed its stake in McKesson Co. (NYSE:MCK) by 45.0% in the 1st quarter, Holdings Channel reports. The firm owned 8,932 shares of the company’s stock after selling 7,308 shares during the period. Tyers Asset Management LLC’s holdings in McKesson were worth $1,045,000 at the end of the most recent quarter.
Several other large investors also recently bought and sold shares of MCK. Proficio Capital Partners LLC lifted its stake in shares of McKesson by 161.2% in the 4th quarter. Proficio Capital Partners LLC now owns 222 shares of the company’s stock valued at $25,000 after purchasing an additional 137 shares during the last quarter. Mark Sheptoff Financial Planning LLC bought a new stake in shares of McKesson in the 1st quarter valued at approximately $27,000. Smart Portfolios LLC bought a new stake in shares of McKesson in the 1st quarter valued at approximately $35,000. Investors Research Corp bought a new stake in shares of McKesson in the 1st quarter valued at approximately $36,000. Finally, Dubuque Bank & Trust Co. lifted its stake in shares of McKesson by 106.7% in the 1st quarter. Dubuque Bank & Trust Co. now owns 341 shares of the company’s stock valued at $40,000 after purchasing an additional 176 shares during the last quarter. 87.38% of the stock is owned by institutional investors and hedge funds.
In other McKesson news, CEO Brian Scott Tyler sold 1,488 shares of McKesson stock in a transaction dated Thursday, May 30th. The stock was sold at an average price of $125.49, for a total transaction of $186,729.12. Following the completion of the sale, the chief executive officer now owns 12,192 shares of the company’s stock, valued at approximately $1,529,974.08. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Britt J. Vitalone sold 832 shares of McKesson stock in a transaction dated Friday, May 24th. The stock was sold at an average price of $129.17, for a total value of $107,469.44. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 6,174 shares of company stock worth $804,583. 0.87% of the stock is owned by company insiders.
MCK stock traded down $1.08 on Friday, hitting $133.76. 329,831 shares of the company’s stock were exchanged, compared to its average volume of 1,428,240. McKesson Co. has a 12-month low of $106.11 and a 12-month high of $151.24. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.02 and a quick ratio of 0.58. The company has a market cap of $25.53 billion, a price-to-earnings ratio of 9.86, a price-to-earnings-growth ratio of 1.35 and a beta of 1.08.
McKesson (NYSE:MCK) last announced its earnings results on Wednesday, May 8th. The company reported $3.69 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $3.66 by $0.03. McKesson had a return on equity of 29.02% and a net margin of 0.02%. The firm had revenue of $52.43 billion for the quarter, compared to the consensus estimate of $53.14 billion. During the same period in the previous year, the business earned $3.49 EPS. The firm’s revenue for the quarter was up 1.6% on a year-over-year basis. As a group, equities research analysts anticipate that McKesson Co. will post 14.14 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Monday, July 1st. Investors of record on Monday, June 3rd will be paid a dividend of $0.39 per share. The ex-dividend date is Friday, May 31st. This represents a $1.56 annualized dividend and a yield of 1.17%. McKesson’s dividend payout ratio (DPR) is 11.50%.
Several equities research analysts have recently issued reports on the company. ValuEngine raised McKesson from a “strong sell” rating to a “sell” rating in a research note on Wednesday, May 8th. Zacks Investment Research lowered McKesson from a “hold” rating to a “sell” rating in a research note on Thursday, May 2nd. Finally, Wolfe Research assumed coverage on McKesson in a research note on Tuesday, April 2nd. They set an “outperform” rating for the company. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and five have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $132.39.
McKesson Company Profile
McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices.
See Also: Net Margin
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Co. (NYSE:MCK).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.